Related references
Note: Only part of the references are listed.Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer
Hee Jin Lee et al.
JOURNAL OF CLINICAL PATHOLOGY (2016)
The immune microenvironment of breast ductal carcinoma in situ
Elizabeth Thompson et al.
MODERN PATHOLOGY (2016)
Clinicopathological and prognostic significance of FOXP3+tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysis
Daqing Jiang et al.
BMC CANCER (2015)
Treatment Selection for Patients with Ductal Carcinoma In Situ (DCIS) of the Breast Using the University of Southern California/Van Nuys (USC/VNPI) Prognostic Index
Melvin J. Silverstein et al.
BREAST JOURNAL (2015)
Role of inflammatory infiltrates in triple negative breast cancer
Hirofumi Matsumoto et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
Correlation of histopathologic features of ductal carcinoma in situ of the breast with the oncotype DX DCIS score
Adriana Knopfelmacher et al.
MODERN PATHOLOGY (2015)
Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC)
Sylvia Adams et al.
ONCOIMMUNOLOGY (2015)
Rethinking the Standard for Ductal Carcinoma In Situ Treatment
Laura Esserman et al.
JAMA ONCOLOGY (2015)
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ
Steven A. Narod et al.
JAMA ONCOLOGY (2015)
Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study
Minoru Miyashita et al.
BREAST CANCER RESEARCH (2015)
The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis
Ezzeldin M. Ibrahim et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Ductal Carcinoma In Situ of the Breast
Kalliopi P. Siziopikou
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast
Aseem Lal et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
New Insights into the Role of the Immune Microenvironment in Breast Carcinoma
Luis de la Cruz-Merino et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
The role of tumor-associated macrophages in breast cancer progression
Elias Obeid et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
CD4+ follicular helper T cell infiltration predicts breast cancer survival
Chunyan Gu-Trantien et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
Lawrence J. Solin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Predictors of Local Recurrence in a Population-Based Cohort of Women with Ductal Carcinoma In Situ Treated with Breast Conserving Surgery Alone
Elaine S. Wai et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software
Lee Kamentsky et al.
BIOINFORMATICS (2011)
Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome
Michael J. Campbell et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics
Rita A. Mukhtar et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Risk Factors for Invasive Breast Cancer When Core Needle Biopsy Shows Ductal Carcinoma In Situ
Emil D. Kurniawan et al.
ARCHIVES OF SURGERY (2010)
Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ
M. Sharma et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Regulatory T cells and breast cancer: implications for immunopathogenesis
Maria Angelica Ehara Watanabe et al.
CANCER AND METASTASIS REVIEWS (2010)
Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast
Lars Holmberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Microinvasive carcinoma of the breast
Simonetta Bianchi et al.
PATHOLOGY & ONCOLOGY RESEARCH (2008)
Magnetic resonance imaging captures the biology of ductal carcinoma in situ
Laura J. Esserman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-Year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group
Nina Bijker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Anne E. Carpenter et al.
GENOME BIOLOGY (2006)
The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast
MJ Silverstein
AMERICAN JOURNAL OF SURGERY (2003)
Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial
WD George et al.
LANCET (2003)
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853
N Bijker et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
